Establishing endpoints in canine myotubular myopathy for clinical translation
建立犬肌管肌病的临床转化终点
基本信息
- 批准号:8543634
- 负责人:
- 金额:$ 19.77万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-09-12 至 2014-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAffectAgeAge-YearsAmino Acid SubstitutionAnimal ModelAtrophicBenchmarkingBiologicalBiological AssayBiopsyBirthCanis familiarisCentronuclear myopathyCessation of lifeCharacteristicsClinicalClinical ResearchClinical TrialsClinical assessmentsConsultationsContractureDNA SequenceDataDevelopmentDiseaseDisease ProgressionDoseFemaleFutureGenesGenetic CarriersGenotypeHindlimbHistopathologyHumanInheritedJointsKnock-outLaboratoriesLabradorLifeLimb structureMaintenanceMeasurementMeasuresMethodsModelingMolecularMusMuscleMuscle WeaknessMuscle functionMuscular AtrophyMutationMyopathyNeuromuscular DiseasesPathologyPatientsPerformance StatusPhenotypePhosphatidylinositolsPhosphoric Monoester HydrolasesPhysiologicalPoint MutationProgressive Clinical CourseProtein Tyrosine PhosphataseProteinsResearch DesignResearch PersonnelRespiratory FailureRespiratory InsufficiencyRespiratory physiologyRestSkeletal MuscleSupportive careSystemTarsal JointsTestingTherapeutic StudiesTidal VolumeTimeTimeLineTransgenesTranslatingTranslational ResearchTranslationsTreatment EfficacyX-linked myotubular myopathybaseboysclinically relevantdesigndisease phenotypeeffective therapygene replacementgene therapygenetic pedigreemalemulticatalytic endopeptidase complexmuscle strengthmutantmyotubularinnoveloutcome forecastpre-clinicalpreclinical studyprematurepressurepublic health relevancerespiratoryresponsestemsuccess
项目摘要
DESCRIPTION (provided by applicant): In patients, X-linked myotubular myopathy (XLMTM) is caused by mutation in myotubularin (MTM1) and results in profound muscular weakness, respiratory failure and premature death. Most patients succumb to respiratory complications within 12 months of birth. Currently, there is no cure for this inherited disease, stemming, in par, from the lack of animal models that reflect both the genotype and phenotype of the human condition. Recently, a canine model of XLMTM was identified, and a genetic carrier of the disease was acquired. The establishment of the first XLMTM canine colony now allows investigators to develop and exploit a novel clinically-relevant animal model for pre-clinical trias. As a prerequisite to future preclinical trials, the onset, progression and pathophysiologic characteristics of the canine model will first require careful baseline studies. As such, the specific aims are: Specific Aim 1. Establish the time course and define the characteristics of skeletal muscle histopathology in XLMTM dogs through analysis of serial biopsies. Specific Aim 2. Establish the time course of progressive clinical decline in XLMTM dogs.
描述(由申请方提供):在患者中,X连锁肌管性肌病(XLM TM)由肌管蛋白(MTM1)突变引起,并导致严重肌无力、呼吸衰竭和过早死亡。大多数患者在出生后12个月内死于呼吸系统并发症。目前,还没有治愈这种遗传性疾病的方法,原因是缺乏反映人类疾病基因型和表型的动物模型。最近,XLMTM的犬模型被鉴定,并且获得了该疾病的遗传携带者。第一个XLMTM犬群的建立使研究人员能够开发和利用一种新的临床相关动物模型进行临床前试验。作为未来临床前试验的先决条件,犬模型的发病、进展和病理生理学特征将首先需要仔细的基线研究。因此,具体目标是:具体目标1。通过对系列活检的分析,确定XLMTM犬骨骼肌组织病理学的时间进程并确定其特征。具体目标2。建立XLMTM犬进行性临床下降的时间过程。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Gene therapy in monogenic congenital myopathies.
单基因先天性肌病的基因治疗。
- DOI:10.1016/j.ymeth.2015.10.004
- 发表时间:2016
- 期刊:
- 影响因子:0
- 作者:Guan,Xuan;Goddard,MelissaA;Mack,DavidL;Childers,MartinK
- 通讯作者:Childers,MartinK
Respiratory assessment in centronuclear myopathies.
中心核肌病的呼吸评估。
- DOI:10.1002/mus.24249
- 发表时间:2014
- 期刊:
- 影响因子:3.4
- 作者:Smith,BarbaraK;Goddard,Melissa;Childers,MartinK
- 通讯作者:Childers,MartinK
Regenerative rehabilitation: a new future?
- DOI:10.1097/phm.0000000000000211
- 发表时间:2014-11
- 期刊:
- 影响因子:3
- 作者:Perez-Terzic C;Childers MK
- 通讯作者:Childers MK
Validity of a Neurological Scoring System for Canine X-Linked Myotubular Myopathy.
犬 X 连锁肌管肌病神经评分系统的有效性。
- DOI:10.1089/humc.2015.049
- 发表时间:2015
- 期刊:
- 影响因子:0
- 作者:Snyder,JessicaM;Meisner,Allison;Mack,David;Goddard,Melissa;Coulter,IanT;Grange,Robert;Childers,MartinK
- 通讯作者:Childers,MartinK
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Martin K Childers其他文献
Martin K Childers的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Martin K Childers', 18)}}的其他基金
Gene therapy in canine myotubular myopathy for clinical translation
犬肌管肌病的基因治疗的临床转化
- 批准号:
8505076 - 财政年份:2013
- 资助金额:
$ 19.77万 - 项目类别:
Gene therapy in canine myotubular myopathy for clinical translation
犬肌管肌病的基因治疗的临床转化
- 批准号:
8668138 - 财政年份:2013
- 资助金额:
$ 19.77万 - 项目类别:
Gene therapy in canine myotubular myopathy for clinical translation
犬肌管肌病的基因治疗的临床转化
- 批准号:
8875742 - 财政年份:2013
- 资助金额:
$ 19.77万 - 项目类别:
Establishing endpoints in canine myotubular myopathy for clinical translation
建立犬肌管肌病的临床转化终点
- 批准号:
8243315 - 财政年份:2012
- 资助金额:
$ 19.77万 - 项目类别:
Induced Pluripotent Stem Cells in Canine Muscular Dystrophy
诱导多能干细胞治疗犬肌营养不良症
- 批准号:
7872576 - 财政年份:2010
- 资助金额:
$ 19.77万 - 项目类别:
Induced Pluripotent Stem Cells in Canine Muscular Dystrophy
诱导多能干细胞治疗犬肌营养不良症
- 批准号:
8067098 - 财政年份:2010
- 资助金额:
$ 19.77万 - 项目类别:
Leupeptin in a Canine Model of Duchenne Muscular Dystrophy
杜氏肌营养不良犬模型中的亮肽素
- 批准号:
6968002 - 财政年份:2005
- 资助金额:
$ 19.77万 - 项目类别:
Leupeptin in a Canine Model of Duchenne Muscular Dystrophy
杜氏肌营养不良犬模型中的亮肽素
- 批准号:
7280088 - 财政年份:2005
- 资助金额:
$ 19.77万 - 项目类别:
MUSCLE RESPONSE TO STRESS IN CANINE MUSCULAR DYSTROPHY
犬肌营养不良症的肌肉对压力的反应
- 批准号:
2725216 - 财政年份:1999
- 资助金额:
$ 19.77万 - 项目类别:
MUSCLE RESPONSE TO STRESS IN CANINE MUSCULAR DYSTROPHY
犬肌营养不良症的肌肉对压力的反应
- 批准号:
6520611 - 财政年份:1999
- 资助金额:
$ 19.77万 - 项目类别:
相似海外基金
Hormone therapy, age of menopause, previous parity, and APOE genotype affect cognition in aging humans.
激素治疗、绝经年龄、既往产次和 APOE 基因型会影响老年人的认知。
- 批准号:
495182 - 财政年份:2023
- 资助金额:
$ 19.77万 - 项目类别:
Investigating how alternative splicing processes affect cartilage biology from development to old age
研究选择性剪接过程如何影响从发育到老年的软骨生物学
- 批准号:
2601817 - 财政年份:2021
- 资助金额:
$ 19.77万 - 项目类别:
Studentship
RAPID: Coronavirus Risk Communication: How Age and Communication Format Affect Risk Perception and Behaviors
RAPID:冠状病毒风险沟通:年龄和沟通方式如何影响风险认知和行为
- 批准号:
2029039 - 财政年份:2020
- 资助金额:
$ 19.77万 - 项目类别:
Standard Grant
Neighborhood and Parent Variables Affect Low-Income Preschool Age Child Physical Activity
社区和家长变量影响低收入学龄前儿童的身体活动
- 批准号:
9888417 - 财政年份:2019
- 资助金额:
$ 19.77万 - 项目类别:
The affect of Age related hearing loss for cognitive function
年龄相关性听力损失对认知功能的影响
- 批准号:
17K11318 - 财政年份:2017
- 资助金额:
$ 19.77万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
9320090 - 财政年份:2017
- 资助金额:
$ 19.77万 - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
10166936 - 财政年份:2017
- 资助金额:
$ 19.77万 - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
9761593 - 财政年份:2017
- 资助金额:
$ 19.77万 - 项目类别:
How age dependent molecular changes in T follicular helper cells affect their function
滤泡辅助 T 细胞的年龄依赖性分子变化如何影响其功能
- 批准号:
BB/M50306X/1 - 财政年份:2014
- 资助金额:
$ 19.77万 - 项目类别:
Training Grant
Inflamm-aging: What do we know about the effect of inflammation on HIV treatment and disease as we age, and how does this affect our search for a Cure?
炎症衰老:随着年龄的增长,我们对炎症对艾滋病毒治疗和疾病的影响了解多少?这对我们寻找治愈方法有何影响?
- 批准号:
288272 - 财政年份:2013
- 资助金额:
$ 19.77万 - 项目类别:
Miscellaneous Programs